Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers

Dr. Mark Agulnik, MD

Accepting New Patients

(31 Ratings)

Specializes in: Medical Oncology and Adult Oncology

McGill University Faculty of Medicine

Professional interests include: leukemia, lymphoma, lung cancer, and more.

125 W. Huntington Drive Building A - Suite A200 Building A - Suite A200
Arcadia, CA 91007

(626) 574-2800

Dr. Mark Agulnik, MD is a medical oncologist in DUARTE, CA specializing in medical oncology and adult oncology. He graduated from McGill University Faculty of Medicine. Dr. Mark Agulnik, MD is affiliated with Keck Medical Center of USC and USC CARE MEDICAL GROUP INC.

Office Locations

1500 EAST DUARTE ROAD
DUARTE, CA 91010

open_in_new

Keck Medical Center of USC

125 W. Huntington Drive Building A - Suite A200 Building A - Suite A200
Arcadia, CA 91007

(626) 574-2800

open_in_new

Keck Medical Center of USC

1441 Eastlake Avenue
Los Angeles, CA 90033

1-800-872-2273

open_in_new

1500 San Pablo Street
Los Angeles, CA 90033

open_in_new

Some issues Dr. Mark Agulnik, MD can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

In The News

“In this exclusive MedPage Today video, Mark Agulnik, MD, sarcoma section chief at the City of Hope Comprehensive Cancer Center in Duarte, California, explains the relevance of the study to his...”—"Doxorubicin-Trabectedin Impresses in Leiomyosarcoma", MedPage Today, October 2021

“said Mark Agulnik, an oncologist at Northwestern University's Robert H. Lurie Comprehensive Cancer Center in Chicago.”—"Gwynn's death renews calls to ban chewing tobacco | HeraldNet.com", Herald Net, June 2014

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2012 were lab tests, chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	344
blood draw	223
chemotherapy	344
doctor visit	363
hospital care	104
inpatient care	104
lab tests	910
minimally invasive procedures	343

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2013 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	397
blood draw	196
chemotherapy	397
doctor visit	328
hormone therapy	23
hospital care	69
inpatient care	69
lab tests	767
minimally invasive procedures	416

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	265
Female	254

**Ethnicity**
Non-Hispanic White	357
Black	97
Hispanic	32
Asian	17
Other	16
Native American	0

**Age**
From 65 to 74	227
From 75 to 84	153
85 and over	39
Less than 65	100

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2013

Hypertension	64
High Cholesterol	42
Stroke	7
Ischemic Heart Disease	30
Depression	23
Chronic Kidney Disease	38
Asthma	6
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	19
Chronic Obstructive Pulmonary Disease	16
Diabetes	25
Dementia	7
Cancer	31

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2014 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	337
blood draw	199
chemotherapy	337
doctor visit	467
hospital care	141
inpatient care	141
lab tests	695
minimally invasive procedures	356

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	282
Female	224

**Ethnicity**
Non-Hispanic White	356
Black	88
Hispanic	35
Asian	15
Other	12
Native American	0

**Age**
From 65 to 74	254
From 75 to 84	134
85 and over	35
Less than 65	83

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2014

Hypertension	61
High Cholesterol	42
Stroke	4
Ischemic Heart Disease	32
Depression	21
Chronic Kidney Disease	42
Asthma	5
Osteoperosis	9
Atrial Fibrilation	9
Heart Failure	21
Chronic Obstructive Pulmonary Disease	15
Diabetes	25
Dementia	4
Cancer	35

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2015 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	391
blood draw	186
chemotherapy	391
doctor visit	451
lab tests	706
minimally invasive procedures	426

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	536
Female	424

**Ethnicity**
Non-Hispanic White	696
Black	152
Hispanic	52
Asian	34
Other	0
Native American	0

**Age**
From 65 to 74	488
From 75 to 84	254
85 and over	64
Less than 65	154

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2015

Hypertension	60
High Cholesterol	46
Stroke	6
Ischemic Heart Disease	34
Depression	24
Chronic Kidney Disease	37
Asthma	11
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	18
Chronic Obstructive Pulmonary Disease	13
Diabetes	26
Dementia	6
Cancer	35

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2016 were lab tests, minimally invasive procedures, blood draw and chemotherapy.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	179
blood draw	186
chemotherapy	179
doctor visit	501
hospital care	71
inpatient care	71
lab tests	717
minimally invasive procedures	213

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	221
Female	207

**Ethnicity**
Non-Hispanic White	294
Black	83
Hispanic	23
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	218
From 75 to 84	116
85 and over	28
Less than 65	66

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2016

Hypertension	66
High Cholesterol	45
Stroke	7
Ischemic Heart Disease	37
Depression	20
Chronic Kidney Disease	41
Asthma	18
Osteoperosis	9
Atrial Fibrilation	10
Heart Failure	21
Chronic Obstructive Pulmonary Disease	17
Diabetes	27
Dementia	9
Cancer	33

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2017 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	403
blood draw	246
chemotherapy	403
doctor visit	762
hormone therapy	15
hospital care	49
inpatient care	49
lab tests	1084
minimally invasive procedures	454

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	302
Female	244

**Ethnicity**
Non-Hispanic White	390
Black	83
Hispanic	36
Asian	18
Other	0
Native American	0

**Age**
From 65 to 74	314
From 75 to 84	132
85 and over	26
Less than 65	74

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2017

Hypertension	66
High Cholesterol	39
Stroke	7
Ischemic Heart Disease	38
Depression	21
Chronic Kidney Disease	42
Asthma	6
Osteoperosis	8
Atrial Fibrilation	10
Heart Failure	19
Chronic Obstructive Pulmonary Disease	14
Diabetes	28
Dementia	8
Cancer	30

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2018 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and lab tests.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	387
chemotherapy	387
doctor visit	679
hormone therapy	21
hospital care	60
inpatient care	60
lab tests	190
minimally invasive procedures	452

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	289
Female	269

**Ethnicity**
Non-Hispanic White	377
Black	91
Hispanic	51
Asian	0
Other	22
Native American	0

**Age**
From 65 to 74	280
From 75 to 84	155
85 and over	35
Less than 65	88

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2018

Hypertension	65
High Cholesterol	47
Stroke	4
Ischemic Heart Disease	39
Depression	20
Chronic Kidney Disease	43
Asthma	6
Osteoperosis	8
Atrial Fibrilation	9
Heart Failure	20
Chronic Obstructive Pulmonary Disease	13
Diabetes	27
Dementia	7
Cancer	34

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2019 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	415
chemotherapy	415
doctor visit	635
hormone therapy	28
hospital care	138
inpatient care	138
minimally invasive procedures	486
preventive care	14
vaccines	14

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	352
Female	268

**Ethnicity**
Non-Hispanic White	422
Black	92
Hispanic	51
Asian	23
Other	32
Native American	0

**Age**
From 65 to 74	326
From 75 to 84	172
85 and over	32
Less than 65	90

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2019

Hypertension	67
High Cholesterol	50
Stroke	5
Ischemic Heart Disease	39
Depression	23
Chronic Kidney Disease	43
Asthma	6
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	21
Chronic Obstructive Pulmonary Disease	14
Diabetes	27
Dementia	8
Cancer	30

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2020 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

biological response modifier (BRM) therapy	139
chemotherapy	139
doctor visit	157
hospital care	75
inpatient care	75
minimally invasive procedures	179

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	191
Female	143

**Ethnicity**
Non-Hispanic White	235
Black	43
Hispanic	22
Asian	0
Other	18
Native American	0

**Age**
From 65 to 74	167
From 75 to 84	98
85 and over	22
Less than 65	47

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2020

Hypertension	63
High Cholesterol	49
Stroke	4
Ischemic Heart Disease	37
Depression	23
Chronic Kidney Disease	44
Asthma	5
Osteoperosis	12
Atrial Fibrilation	14
Heart Failure	24
Chronic Obstructive Pulmonary Disease	13
Diabetes	30
Dementia	10
Cancer	31

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA during 2021 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

doctor visit	376
hospital care	54
inpatient care	54

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	76
Female	82

**Ethnicity**
Non-Hispanic White	78
Black	0
Hispanic	33
Asian	27
Other	0
Native American	0

**Age**
From 65 to 74	75
From 75 to 84	40
85 and over	15
Less than 65	28

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2021

Hypertension	69
High Cholesterol	57
Stroke	8
Ischemic Heart Disease	39
Depression	22
Chronic Kidney Disease	47
Asthma	10
Osteoperosis	11
Atrial Fibrilation	13
Heart Failure	28
Chronic Obstructive Pulmonary Disease	12
Diabetes	33
Dementia	12
Cancer	27

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

doctor visit	535

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	86
Female	97

**Ethnicity**
Non-Hispanic White	94
Black	0
Hispanic	42
Asian	33
Other	0
Native American	0

**Age**
From 65 to 74	89
From 75 to 84	51
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Mark Agulnik, MD in 2022

Hypertension	72
High Cholesterol	66
Stroke	8
Ischemic Heart Disease	23
Depression	17
Chronic Kidney Disease	23
Asthma	16
Osteoperosis	19
Atrial Fibrilation	18
Heart Failure	19
Chronic Obstructive Pulmonary Disease	17
Diabetes	30
Dementia	8
Cancer	38

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Mark Agulnik, MD for Medicare patients.

The highest averages for the top procedures that Dr. Mark Agulnik, MD treated as a medical oncologist in DUARTE, CA were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

biological response modifier (BRM) therapy	332
blood draw	206
chemotherapy	332
doctor visit	477
hormone therapy	21
hospital care	84
inpatient care	84
lab tests	724
minimally invasive procedures	369
preventive care	14
vaccines	14

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Mark Agulnik, MD.

**Gender**
Male	236
Female	201

**Ethnicity**
Black / African American	66
Asian / Pacific Islander	15
Non-Hispanic White	299
Native American / Alaskan Native	0
Hispanic	34
Other	9

**Age**
75 to 84	118
85 and over	26
Less than 65	66
65 to 74	221

Average of Total of Conditions of Medicare patients treated by Dr. Mark Agulnik, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Mark Agulnik, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	59
High Cholesterol	43
Stroke	5
Ischemic Heart Disease	31
Depression	19
Chronic Kidney Disease	36
Asthma	8
Osteoporosis	9
Heart Failure	19
Chronic Obstructive Pulmonary Disease	13
Diabetes	25
Atrial Fibrillation	10
Dementia	7
Cancer	29

Education & Training

Dr. Mark Agulnik, MD graduated from McGill University Faculty of Medicine. He completed residency at Mount Sinai Hospital, Chicago. He has a state license in Illinois.

Medical School: McGill University Faculty of Medicine

Residency: Mount Sinai Hospital, Chicago

Licensed In: Illinois

Affiliations & Hospitals

Dr. Mark Agulnik, MD is associated with these hospitals and organizations:

Keck Medical Center of USC

USC CARE MEDICAL GROUP INC

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Mark Agulnik, MD appears to accept the following insurance providers: Humana ChoiceCare Network, Great-West Healthcare, Blue Shield of California, MultiPlan, TriWest, United Healthcare, Interplan, Aetna, Medicare, Coventry, Cigna, GEHA, Anthem, First Health, Private Healthcare Systems (PHCS), Beech Street, PacifiCare, Health Net, Brand New Day, Marian Health Services, Watchtower, Health Net Covered California, Kern Health Systems, Laundry and Dry Cleaning Workers Health & Welfare, USC Network, Take Care (GUAM), Union Roofers Health & Welfare Fund, Blue Shield Covered California, Presbyterian Intercommunity Hospital, NEXT and Health Plans of Nevada.

Insurance Accepted by Provider includes:

According to our sources, Dr. Mark Agulnik, MD accepts the following insurance providers:

Humana ChoiceCare Network

Great-West Healthcare

Blue Shield of California

MultiPlan

TriWest

United Healthcare

Interplan

Aetna

Medicare

Coventry

Cigna

GEHA

Anthem

First Health

Private Healthcare Systems (PHCS)

Beech Street

PacifiCare

Health Net

Brand New Day

Marian Health Services

Watchtower

Health Net Covered California

Kern Health Systems

Laundry and Dry Cleaning Workers Health & Welfare

USC Network

Take Care (GUAM)

Union Roofers Health & Welfare Fund

Blue Shield Covered California

Presbyterian Intercommunity Hospital

Health Plans of Nevada

Ratings & Reviews

Dr. Mark Agulnik, MD has an exceptional overall rating with an average of 4.97 out of 5 stars based on 31 ratings. We collect ratings and reviews of Dr. Mark Agulnik, MD from all over the web to help you find the right in DUARTE, CA.

4.97

Overall Rating

(31 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Mark Agulnik, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Bayer HealthCare Pharmaceuticals Inc.	$99,069 Vitrakvi $83,862	Stivarga $6,665	Nexavar $2,864	Non-Covered $2,560	Aliqopa $12	Other $3,106
Novartis Pharmaceuticals Corporation	$75,466 VOTRIENT - SARCOMA $24,653	NON BRAND $20,771	VOTRIENT $19,012	Gleevec $3,277	AFINITOR $702	Other $7,051
Janssen Scientific Affairs, LLC	$64,993 YONDELIS $46,099	ZYTIGA $18,893
GlaxoSmithKline, LLC.	$48,234 VOTRIENT ARCC $22,657	VOTRIENT $21,376	$4,201
Eli Lilly and Company	$46,780 CYRAMZA $67	$46,713
Other	$194,736 LIBTAYO $33,874	QINLOCK $27,207	OPDIVO $18,025	FYARRO $11,213	Halaven $10,607	Other $93,810

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$279,760
Consulting Fee	$149,748
Travel and Lodging	$42,063
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program	$26,790
Honoraria	$18,300
Other	$12,617

Research Payments

Dr. Mark Agulnik, MD has received 227 research payments totaling $15,873,841.

Biography

Dr. Mark Agulnik is an adult oncology and medical oncology specialist. Dr. Agulnik's patients gave him an average rating of 5.0 stars (out of 5). His areas of expertise include the following: leukemia, throat cancer, and lung cancer. He is affiliated with Keck Medical Center of USC. Anthem, PacifiCare, and Blue California seem to be the insurance carriers that Dr. Agulnik accepts. According to Doctor.com, new patients are welcome to contact Dr. Agulnik's office in DUARTE, CA. After completing medical school at McGill University Faculty of Medicine, he performed his residency at Mount Sinai Hospital, Chicago.